Evaluation of the Biologics Program 1999-2000 to 2012-2013 / prepared by Evaluation Directorate, Health Canada and the Public Health Agency of Canada.: H14-491/2014E-PDF
"The Biologics Program (BP) is managed through the Health Products and Food Branch (HPFB) of Health Canada. The BP regulates drugs and products derived from living sources, as well as radiopharmaceuticals. Products derived from living sources include blood and blood components and blood products; vaccines; hormones; enzymes; cytokines; monoclonal antibodies; gene therapy products; cells, tissues, and organs; xenografts; and semen for assisted conception"--Executive summary, page ii.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.932074&sl=0
| Department/Agency | Canada. Health Canada. Evaluation Directorate, issuing body. Public Health Agency of Canada. Evaluation Directorate, issuing body. |
|---|---|
| Title | Evaluation of the Biologics Program 1999-2000 to 2012-2013 / prepared by Evaluation Directorate, Health Canada and the Public Health Agency of Canada. |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Cover title. Issued also in French under title: Évaluation du Programme des produits biologiques de 1999-2000 à 2012-2013. Includes bibliographical references (pages 121-130, pages 148-150). |
| Publishing information | [Ottawa] : Health Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, May 2014. |
| Description | 1 online resource (xx, 150 pages) : illustrations, graphs |
| Catalogue number |
|
| Subject terms | Biologicals -- Canada -- Evaluation. Biologicals -- Risk assessment -- Canada. |